MALAT1 Polymorphisms and Lung Cancer Susceptibility in a Chinese Northeast Han Population
- PMID: 35928715
- PMCID: PMC9346381
- DOI: 10.7150/ijms.73026
MALAT1 Polymorphisms and Lung Cancer Susceptibility in a Chinese Northeast Han Population
Abstract
Background: LncRNA MALAT1 (metastasis-associated lung adenocarcinoma transcript 1) was competitive endogenous RNA (ceRNA) involved in various molecular processes for metastasis development in lung cancer. Single nucleotide polymorphisms (SNPs) in MALAT1 gene might be predictive markers for lung cancer. In our study, we selected rs619586 and rs3200401 in MALAT1 gene to explore their effects on lung cancer susceptibility. Methods: The case-control study included 444 lung cancer cases and 460 healthy controls. Genotyping was performed by Taqman allelic discrimination method. Logistic regression, Student t-test, and Chi-square test (χ2 ) were used to analyze the data. Results: The findings of the study showed that rs3200401 was significantly associated with the risk of non-small cell lung cancer (NSCLC) and lung squamous cell carcinoma (LUSC). Compared with homozygous CC genotype, CT heterozygous genotype decreased risk of NSCLC (Pa = 0.034) and LUSC (Pa = 0.025). In addition, no statistical association was detected between rs619586 and lung cancer susceptibility. The interactions between genes and cigarette smoking were discovered via crossover analysis. However, there were no remarkable gene-environment interactions in additive and multiplicative model. Conclusion: Rs3200401 in lncRNA MALAT1 was associated with the susceptibility of non-small-cell lung cancer and lung squamous cell carcinoma. The gene-environmental (cigarette smoking) interactions were not notable.
Keywords: Interaction.; LncRNA; Lung cancer; MALAT1; Single nucleotide polymorphism.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures
Similar articles
-
LncRNA NEAT1 polymorphisms and lung cancer susceptibility in a Chinese Northeast Han Population: A case-control study.Pathol Res Pract. 2019 Dec;215(12):152723. doi: 10.1016/j.prp.2019.152723. Epub 2019 Oct 31. Pathol Res Pract. 2019. PMID: 31704150
-
Polymorphisms in Long Noncoding RNA-Prostate Cancer-Associated Transcript 1 Are Associated with Lung Cancer Susceptibility in a Northeastern Chinese Population.DNA Cell Biol. 2019 Nov;38(11):1357-1365. doi: 10.1089/dna.2019.4834. Epub 2019 Aug 29. DNA Cell Biol. 2019. PMID: 31464517 Free PMC article.
-
Association of tag single nucleotide polymorphisms (SNPs) at lncRNA MALAT1 with type 2 diabetes mellitus susceptibility in the Chinese Han population: A case-control study.Gene. 2023 Jan 30;851:147008. doi: 10.1016/j.gene.2022.147008. Epub 2022 Oct 23. Gene. 2023. PMID: 36283602
-
A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis.BMC Cancer. 2017 Mar 3;17(1):167. doi: 10.1186/s12885-017-3151-6. BMC Cancer. 2017. PMID: 28253859 Free PMC article.
-
Associations of MALAT1 and its functional single nucleotide polymorphisms with cancer.Pathol Res Pract. 2022 Aug;236:153988. doi: 10.1016/j.prp.2022.153988. Epub 2022 Jun 18. Pathol Res Pract. 2022. PMID: 35759938 Review.
Cited by
-
Long Non-Coding RNAs as Emerging Targets in Lung Cancer.Cancers (Basel). 2023 Jun 10;15(12):3135. doi: 10.3390/cancers15123135. Cancers (Basel). 2023. PMID: 37370745 Free PMC article. Review.
-
The significance of the crosstalk between ubiquitination or deubiquitination and ncRNAs in non-small cell lung cancer.Front Oncol. 2023 Jan 16;12:969032. doi: 10.3389/fonc.2022.969032. eCollection 2022. Front Oncol. 2023. PMID: 36727069 Free PMC article. Review.
-
Evaluation of the clinical significance of long non-coding RNA MALAT1 genetic variants in human lung adenocarcinoma.Aging (Albany NY). 2024 Mar 21;16(6):5740-5750. doi: 10.18632/aging.205675. Epub 2024 Mar 21. Aging (Albany NY). 2024. PMID: 38517388 Free PMC article.
-
Exploring the role of noncoding RNAs in cancer diagnosis, prognosis, and precision medicine.Noncoding RNA Res. 2024 Jul 1;9(4):1315-1323. doi: 10.1016/j.ncrna.2024.06.015. eCollection 2024 Dec. Noncoding RNA Res. 2024. PMID: 39764154 Free PMC article. Review.
-
Migration/Differentiation-Associated LncRNA SENCR rs12420823*C/T: A Novel Gene Variant Can Predict Survival and Recurrence in Patients with Breast Cancer.Genes (Basel). 2022 Oct 31;13(11):1996. doi: 10.3390/genes13111996. Genes (Basel). 2022. PMID: 36360233 Free PMC article.
References
-
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108. - PubMed
-
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. - PubMed
-
- Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. - PubMed
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical